This federal contract award was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company. The contract is for the provision of Orencia 125 mg/ml syringe, a specialty medication, to the agency. The award is a delivery order with a firm fixed price of $4,779.74 and a completion date of April 23, 2024. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. The current award was made on a full and open competition basis without any set-aside designation.
Generated 7/22/24, 9:22 AM